Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/17/2008CN101323855A Chrysanthemum Na+/H- antiport protein gene DmNHX1, encoding protein and use thereof
12/17/2008CN101323854A Rice RDB1 drought resistant gene
12/17/2008CN101323853A Clone and use of transcription factor gene OsWOX20 forroot regulating rice growth and development
12/17/2008CN101323641A Anti-opioid peptide, antagonistic peptide thereof and use thereof
12/17/2008CN101323640A Enzymolysis product inhibiting alpha-glucosidase activity and use thereof
12/17/2008CN101323639A Transcriptional regulation protein, preparation and use thereof
12/17/2008CN101322842A Recombinant Staphylococcus aureus enterotoxin G oral preparation and use
12/17/2008CN101322841A Recombinant Staphylococcus aureus enterotoxin J oral preparation and use
12/17/2008CN100443592C Process for fermentative preparation of L-threonine
12/17/2008CN100443501C Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof
12/17/2008CN100443500C Factor VIII separation
12/17/2008CN100443499C High purity albumin production process
12/17/2008CN100443116C Compositions and methods for treating or preventing pneumococcal infection
12/16/2008US7465850 by expressing a polypeptide from yeast that when expressed will increase the total amount of oil (i.e. triacylglycerols TAG) that is produced in transgenic organisms
12/16/2008US7465849 Acquired resistance genes in plants
12/16/2008US7465794 genetic engineered RNA viruses that express immunology modulators such as cytokines, chemokines, enzymes, cytokine and chemokine antagonist, surface receptors, adhesion molecule or ligands; genetic vaccines
12/16/2008US7465792 Fungi non-LTR retrotransposons and methods related thereto
12/16/2008US7465789 Adenosine receptor
12/16/2008US7465788 polynucleotide and protein of Macaca mulata (rhesus monkey); hematopoietic stem cell marker
12/16/2008US7465787 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases
12/16/2008US7465786 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
12/16/2008US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma
12/16/2008US7465783 Plant peptide with antimicrobial activity
12/16/2008US7465709 Structural formulas based on the repetitive motifs of salivary proline rich proteins mucin and collagen designed to modulate cell and tissue growth division and differentiation
12/16/2008US7465707 Methods of treatment with TR10 polypeptides
12/16/2008US7465706 GDF3 propeptides and related methods
12/16/2008US7465705 Immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies; diabetic neuropathy; brain injury, spinal cord injury
12/16/2008US7465704 Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF)
12/16/2008US7465581 ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
12/16/2008US7465580 vector encoding a derivative of EBNA-1 that is not cytotoxic when expressed efficiently in cells, which supports extrachromosomal replication, maintenance and transcription from extrachromosomal oriP containing vectors but does not substantially activate transcription from host cell genes
12/16/2008US7465574 Recombinant RSV virus expression systems and vaccines
12/16/2008US7465573 for preventing/treating infectious diseases from donor animals during xenotransplantation
12/16/2008US7465572 De-immunized streptokinase
12/16/2008US7465568 isolated nucleic acid molecule consisting of a polynucleotide sequence encoding polypeptides that have been shown to be essential for Candida albicans growth and survival; Fungal Conserved Genes ("FCG"), or Conserved Unknown Reading Frames ("CURFs")
12/16/2008US7465554 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof
12/16/2008US7465552 Patched genes and uses related thereto
12/16/2008US7465550 Method for screening taste-modulating compounds
12/16/2008US7465549 incubating SV2 protein or fragment with levetiracetam or an analog or derivative thereof and a potential binding partner and determining if the potential binding partner modulates the binding of levetiracetam to the SV2 protein
12/16/2008US7465547 sandwich method, are able to quantitatively or qualitatively determine human low-molecular-weight CD14 with high sensitivity and specificity in a simple manner, so that they are useful for the diagnosis of a patient suffering from sepsis
12/16/2008US7465467 Process for the extraction, purification and enzymatic modification of soy 7S globulin α' subunit for use as hypocholesterolemizing agent
12/16/2008US7465464 Populations of cells that express flk-2 receptors
12/16/2008US7465459 Piroplasmid vaccine
12/16/2008US7465456 entirely from cloned cDNA; production of attenuated live influenza A and B virus suitable for vaccines, such as live virus vaccine formulations; increasing growth of a reassortant influenza virus in embryonated eggs
12/16/2008US7465453 pharmaceutical composition containing a therapeutically effective amount of the CKLF1 C-terminal polypeptide used for treating the HIV infection, allergic disease, allograft rejection, diseases in brain and autoimmune diseases
12/16/2008US7465452 Tumor antigen
12/16/2008US7465451 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
12/16/2008US7465449 Anti-αvβ6 antibodies
12/16/2008US7465448 Chemokine receptor antagonists as therapeutic agents
12/16/2008US7465447 Population of purified Fc-EPO fusion proteins for administration to mammal, proteins comprising Fc portion towards N-terminus and erythropoietin portion towards C-terminus, population having average of 11-28 sialic acid residues per purified Fc-EPO fusion protein; prolonged serum half-life; potency
12/16/2008US7465443 Acellular antibordetella vaccine
12/16/2008US7465442 Reduction of dermal scarring
12/16/2008US7465321 Wet strength; treatingwith reducing agent ; crosslinking; extrusion; freeze drying
12/16/2008US7465293 Syringe for inducing therapeutically-effective proteins
12/16/2008CA2449071C Chimaeric phages
12/16/2008CA2306449C Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
12/16/2008CA2298018C Methods and compositions for inhibiting angiogenesis
12/16/2008CA2295519C A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
12/16/2008CA2285667C Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a
12/16/2008CA2284397C Amino acid modified polypeptides
12/16/2008CA2268099C Screening methods for glucocorticoid receptor binding substances using tripterygium wilfordii preparations
12/16/2008CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
12/16/2008CA2253632C Compositions and methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
12/16/2008CA2195753C Determination of a specific immunoglobulin using multiple antigens
12/16/2008CA2154581C Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease
12/11/2008WO2008151197A2 Tumor-derived endogenous toll-like receptor 4 ligands
12/11/2008WO2008151078A1 Methods and compositions for modulating bmp-10 activity
12/11/2008WO2008151055A1 Diagnosing neurodegenerative diseases
12/11/2008WO2008151037A1 Peptide-based stat inhibitor
12/11/2008WO2008150929A1 Topical compositions comprising a macromolecule and methods of using same
12/11/2008WO2008150821A1 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1)
12/11/2008WO2008150383A1 Csf-1r mutants
12/11/2008WO2008150196A1 Oxygen-transferring blood substitute
12/11/2008WO2008150158A1 Novel plant virus designated tomato marchitez virus
12/11/2008WO2008150101A2 Chimeric polypeptide including a mussel adheisve protein and extracellular matrix
12/11/2008WO2008150025A1 Novel bone mass increasing agent
12/11/2008WO2008150023A2 Method for producing antagonist of growth factor
12/11/2008WO2008149526A1 Novel sugar-chain-modified haptoglobin
12/11/2008WO2008148872A1 Yield enhancement in plants by modulation of maize mads box transcription factor zmm28
12/11/2008WO2008148839A2 Long-acting polymeric prodrugs of exendin
12/11/2008WO2008148671A1 Hcv ns3 replicon shuttle vectors
12/11/2008WO2008148575A2 Increased production of a target product via stabilization of mrna
12/11/2008WO2008148545A1 Novel peptides and their use for the treatment of edema
12/11/2008WO2008148463A1 Splice-variants of g-protein coupled receptor ep3 and uses thereof
12/11/2008WO2008148298A1 Improvement of cold tolerance in plants by protein kinase gene oscipk03 from rice
12/11/2008WO2008148193A1 Fhl1 mutations associated with novel x-linked muscular myopathies
12/11/2008WO2008148166A1 Clostridial toxin netb
12/11/2008WO2008110356A3 Protein pi 16 secreted from the heart and uses thereof
12/11/2008WO2008109560A3 Amelioration of cellular stress response
12/11/2008WO2008106131A3 Combination therapy for treatment of immune disorders
12/11/2008WO2008101671A3 Il-4 fc fusion proteins
12/11/2008WO2008088837A3 Expression of hla proteins on non-human cells
12/11/2008WO2008088385A3 Peptides that enhance acetylcholinesterase expression
12/11/2008WO2008069965A3 Novel genes and proteins that home to developing microvessels
12/11/2008WO2008069958A3 Substrate switched ammonia lyases and mutases
12/11/2008WO2008054502A3 Diagnostic and therapeutic methods related to anthrax exposure
12/11/2008WO2008051612A3 Light-mediated anti-cell proliferative compositions and methods
12/11/2008WO2008051421A3 Peptide-cytotoxic conjugates
12/11/2008WO2008048508A3 Prognostic biomarkers in patients with ovarian cancer
12/11/2008WO2008048466A3 Bone resorption disorders
12/11/2008WO2008013983A3 Opsin stabilizing compounds and methods of use